Table 3.
Univariate and multivariate analysis for overall survival
| |
Univariate analysis |
Multivariate analysis |
||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P value | HR | 95% CI | P value | |
| Lung cancer |
1.153 |
0.623 to 2.136 |
0.651 |
– |
– |
– |
| Adenocarcinoma |
1.128 |
0.623 to 2.042 |
0.691 |
– |
– |
– |
| Interval between diagnoses of PE and primary cancer |
0.994 |
0.981 to 1.007 |
0.384 |
– |
– |
– |
| Mediastinal lymphadenopathy |
1.456 |
0.735 to 2.884 |
0.281 |
– |
– |
– |
| Pericardial metastasis on CT |
2.224 |
1.148 to 4.306 |
0.018 |
2.078 |
1.077 to 4.012 |
0.029 |
| Extrathoracic metastasis |
1.818 |
0.980 to 3.373 |
0.058 |
– |
– |
– |
| Abnormal EKG |
1.730 |
0.935 to 3.201 |
0.081 |
– |
– |
– |
| Cytopathologic malignant PE | 2.079 | 1.114 to 3.878 | 0.021 | 1.964 | 1.053 to 3.663 | 0.034 |
PE, pericardial effusion, CT, computed tomography.
Cytopathologically malignant PE included positive PE and/or positive pericardial tissue.